Advertisement
Paper| Volume 40, ISSUE 6, P833-852, December 15, 1985

Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers — A thiol enhanced process

DOI:https://doi.org/10.1016/0049-3848(85)90320-2
Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers — A thiol enhanced process
Previous ArticleGlutathione levels in human platelets display a circadian rhythm in vitro
Next ArticleThe potentiating effect of platelet on plasminogen activation by tissue plasminogen activator
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Fibrinogen and plasma fibronectin were shown to interact in the presence of factor XIIIa. The reaction was enhanced by dithiothreitol and was accompanied by an increase in the turbidity of the solution and the formation of particulate matter and gel structures. At a constant concentration of fibrinogen the turbidity increase was dependent on the fibronectin concentration and at a constant concentration of fibronectin, on the fibrinogen concentration. Kinetic experiments showed that an initial step in the reaction between fibrinogen and fibronectin was the formation of a transient intermediate containing 1 mole of fibrinogen and 1 mole of fibronectin. Transient intermediates of larger molecular weight and containing both fibrinogen and fibronectin were also formed. These heterooligomers eventually reached huge molecular sizes and at early times formed particulate matter that sedimented on centrifugation. The predominant molecular species formed in an equimolar mixture of fibrinogen and fibronectin were heteropolymers. Small amounts of homopolymers composed of fibrinogen and possibly also homopolymers of fibronectin were detected. The results are discussed in terms of reaction mechanism and potential importance of this novel oligomerization pathway in haemostasis, thrombosis and tissue repair.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Mosher D.F.
        Cross-linking of cold-insoluble globulin by fibrinstabilizing factor.
        J. Biol. Chem. 1975; 250: 6614-6621
        • Mosher D.F.
        Action of fibrin-stabilizing factor on cold-insoluble globulin and α2-macroglobulin in clotting plasma.
        J. Biol. Chem. 1976; 251: 1639-1645
        • Okada M.
        • Blomback B.
        • Chang M.D.
        • Horowitz B.
        Fibronectin and fibrin gel structure.
        J. Biol. Chem. 1985; 260: 1811-1820
        • Blomback B.
        • Procyk R.
        • Adamson L.
        • Hessel B.
        FXIII induced gelation of human fibrinogen - an alternative thiol enhanced, thrombin independent pathway.
        Thromb. Res. 1985; 37: 613-628
        • Mosher D.F.
        • Johnson R.B.
        In vitro formation of disulfide-bonded fibronectin multimers.
        J. Biol. Chem. 1983; 258: 6595-6601
        • Keski-Oja J.
        • Mosher D.F.
        • Vaheri A.
        Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII.
        Cell. 1976; 9: 29-35
        • Blomback B.
        • Blomback M.
        Purification of human and bovine fibrinogen.
        Arkiv Kemi. 1957; 10: 415-443
        • Engvall E.
        • Ruoslahti E.
        Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.
        Int. J. Cancer. 1977; 20: 1-5
        • Engvall E.
        Enzyme immunoassay ELISA and EMIT.
        Methods in Enzymology. 1980; 70 (Part A): 419-439
        • Dvilansky A.
        • Britten A.F.H.
        • Loewy A.G.
        Factor XIII assay by an isotope method I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.
        British J. Haematol. 1970; 18: 399-410
        • Lorand L.
        • Gotoh T.
        Fibrinoligase.
        in: The fibrin stabilizing factor system. Methods in Enzymology. 19. 1970: 770-782
        • Curtis C.G.
        • Lorand L.
        Fibrin-stabilizing factor (factor XIII).
        Methods in Enzymology. 1976; 45 (part B): 177-191
        • Fenton II, J.W.
        • Fasco M.J.
        • Stackrow A.B.
        • Aronson D.L.
        • Young A.M.
        • Finlayson J.S.
        Human thrombins.
        in: Production, evaluation, and properties of α-thrombin. J. Biol. Chem.252. 1977: 3587-3598
        • Mosher D.F.
        • Schad P.E.
        • Vann J.M.
        Cross-linking of collagen and fibronec in by factor XIIIa.
        J. Biol. Chem. 1980; 255: 1181-1188
        • Blomback M.
        • Blomback B.
        • Holmovis H.
        Immunological characterization of early fibrinogen degradation products.
        in: Radioimmunoassay of fragments released from the Aa-chain of fibrinogen. Thromb. Res.8. 1976: 567-577
        • Mosesson M.W.
        • Umfleet R.A.
        The cold-insoluble globulin of human plasma.
        J. Biol. Chem. 1970; 215: 5728-5736
        • Horowitz B.
        • Lippin A.
        • Chang M.Y.
        • Shulman R.W.
        • Vandersande J.
        • Stryker M.H.
        • Woods K.R.
        Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
        Transfusion. 1984; 24: 357-362
        • Laemmli U.K.
        Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
        Nature. 1970; 227: 680-685
        • Blomback B.
        • Okada M.
        Fibrin gel structure and clotting time.
        Thromb. Res. 1982; 25: 51-70
        • Chung S.I.
        • Lewis M.S.
        • Folk J.E.
        Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures.
        J. Biol. Chem. 1974; 249: 940-950
        • Curtis C.G.
        • Stenberg P.
        • Chou C-H.J.
        • Gray A.
        • Brown K.L.
        • Lorand L.
        Titration and subunit localization of active center cysteine in fibrinoligase.
        in: (Thrombin-activated fibrin stablizing factor.). Biochem. Biophys. Res. Commun.52. 1973: 51-56
        • Cooke R.D.
        • Pestell T.C.
        • Holbrook J.J.
        Calcium and thiol reactivity of human plasma clotting factor XIII.
        Biochem. J. 1974; 141: 675-682
        • Williams E.C.
        • Janmey P.A.
        • Johnson R.B.
        • Mosher D.F.
        Fibronectin.
        in: Effect of disulfide bond reduction on its physical and functional properties. J. Biol. Chem.258. 1983: 5911-5914
        • Petersen T.E.
        • Thogersen H.C.
        • Skorstengaard K.
        • Vibe-Pedersen K.
        • Sahl P.
        • Sottrup-Jensen L.
        • Magnusson S.
        Partial primary structure of bovine plasma fibronectin: Three types of internal homology.
        in: Proc. Natl. Acad. Sci.80. 1983: 137-141
        • Sobel J.H.
        • Ehrlich P.H.
        • Birken S.
        • Saffran A.J.
        • Canfield R.E.
        Monoclonal antibody to the region of fibronectin involved in cross linking to human fibrin.
        Biochemistry. 1983; 22: 4175-4183
        • Pisano J.J.
        • Finlayson J.S.
        • Peyton M.P.
        Cross-link in fibrin polymerized by factor XIII: L-(γ-glutamyl) lysine.
        Science. 1968; 160: 892-893
        • Ruoslahti E.
        • Vaheri A.
        Interaction of soluble fibroblast surface antigen with fibrinogen and fibrin.
        in: Identity with cold insoluble globulin of human plasma. J. Exper. Med.141. 1975: 497-501
        • Stathakis N.E.
        • Mosesson M.W.
        • Chen A.B.
        • Galanakis D.K.
        Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma.
        Blood. 1978; 51: 1211-1222
        • Hayashi A.
        • Yamadi K.I.
        Voirain structure of the carboxyl-terminal half of human plasma fibronectin.
        J. Biol. Chem. 1983; 258: 3332-3334
        • Sekiguchi K.
        • Hakomori S.
        Domain structure of human plasma fibronectin.
        J. Biol. Chem. 1983; 258: 3967-3973
        • Stemberger A.
        • Hormann H.
        Affinity chromatography on immobilized fibrinogen and fibrin monomer, II The behavior of cold-insoluble globulin.
        Hoppe-Seyler's Z. Physiol. Chem. 1976; 357: 1003-1005
        • Folk J.E.
        Structure and catalytic properties of hepatic transglutaminase.
        N.Y. Acad. Sci. 1972; 202: 59-76
        • Becker C.M.
        Plasma fibronectin enhancement of human fibrinogen polymer formation under physiologic conditions.
        in: Fed. Proc.44. 1985: 1656
        • Smith D.E.
        • Mosher D.F.
        • Johnson R.B.
        • Furcht L.T.
        Immunological identification of two sulfhydryl-containing fragments of human plasma fibronectin.
        J. Biol. Chem. 1982; 257: 5831-5838
        • Vibe-Pedersen K.
        • Sahl P.
        • Skorstengaard K.
        • Petersen T.E.
        Amino acid sequence of a peptide from bovine plasma fibronectin containing a free sulfhydryl group (cysteine).
        FEBS Letters. 1982; 142: 27-30
        • McKeown-Longo P.J.
        • Mosher D.F.
        Mechanism of formation of disulfide-bonded multimers of plasma fibronectin in cell layers of cultured human fibroblasts.
        J. Biol. Chem. 1984; 259: 12210-12215
        • Grinnell F.
        • Feld M.
        • Minter D.
        Fibroblast adhesion to fibrinogen and fibrin substrata: Requirement for cold-insoluble globulin (Plasma fibronectin).
        Cell. 1980; 19: 517-525
        • Saksela O.
        • Alitalo K.
        • Kiistala U.
        • Vaheri A.
        Basal lamina components in experimentally induced skin blisters.
        J. Invest. Dermatol. 1981; 77: 283-286
        • Clark R.A.F.
        • Lanigan J.M.
        • Della Pelle P.
        • Manseau E.
        • Dvorak H.F.
        • Colvin R.B.
        Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization.
        J. Invest. Dermatol. 1982; 79: 264-269
        • Fujikawa L.S.
        • Foster C.S.
        • Harrist T.J.
        • Lanigan J.M.
        • Colvin R.B.
        Fibronectin in healing rabbit corneal wounds.
        Laboratory Investigation. 1981; 45: 120-129
        • Klingemann H.G.
        • Kosukavak M.
        • Hofeler H.
        • Havemann K.
        Fibronectin and factor VIII-related antigen in acute leukaemia.
        Hoppe-Seyler's Z. Physiol. Chem. 1983; 364: 269-277
        • Reilly J.T.
        • MacKie M.J.
        • McVerry B.A.
        Observations on the heterogeneity of fibronectin C.
        Thromb. Res. 1984; 33: 289-295

      Article info

      Publication history

      Accepted: September 2, 1985
      Received: July 15, 1985

      Identification

      DOI: https://doi.org/10.1016/0049-3848(85)90320-2

      Copyright

      © 1985 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX